Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin.
about
Toxicity of polymyxins: a systematic review of the evidence from old and recent studiesGuidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaColistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patientsAerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosisEffect of ventilator-associated tracheobronchitis on outcome in patients without chronic respiratory failure: a case-control studyInhaled Antibiotics for Gram-Negative Respiratory InfectionsColistin in the 21st century.Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa.A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa.Nosocomial Pneumonia: More Than Just Ventilator-Associated.Tuberculosis, lung infections, and interstitial lung disease in AJRCCM 2000.Nosocomial pneumonia in pediatric patients: practical problems and rational solutions.The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.Acinetobacter baumannii: emergence of a successful pathogenNosocomial pneumonia in the intensive care unit: controversies and dilemmas.Inhaled therapeutics for prevention and treatment of pneumoniaColistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.Phenotypic screening of extended-spectrum ß-lactamase and metallo-ß-lactamase in multidrug-resistant Pseudomonas aeruginosa from infected burns.Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter studyAerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia.Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients.Healthcare-associated pneumonia: principles and emerging concepts on management.Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.Inhaled antimicrobial therapies for respiratory infections.Comparative efficacy of two doses of nebulized colistimethate in the eradication of Pseudomonas aeruginosa in children with cystic fibrosis.Polymyxins revisited.Inhaled colistin for treatment of pneumonia due to colistin-only-susceptible Acinetobacter baumannii.Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review.Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an update.Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia.Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens.Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial.Clinical efficacy and safety of colistin treatment in patients with pulmonary infection caused by Pseudomonas aeruginosa or Acinetobacter baumannii: a meta-analysis.Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.An usual approach to treatment of a case of multidrug resistance Pseudomonas aeruginosa peritonitis: parenteral and intraperitoneal aminoglycosides and parenteral colistin.Safety and efficacy of polymyxin B in multidrug resistant Gram-negative severe sepsis and septic shock.Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance.
P2860
Q21092897-16CC1968-AA77-4FB0-BFA4-6367F70A96A1Q22241905-9168502E-7786-4069-925D-92DD8AC4C6CAQ24673399-9F788C9F-24CF-4D94-8E50-4E19183AEA60Q24802737-64880278-F5F2-466A-A859-BB5C4297BFFDQ24811686-00BB802E-A5B9-452F-BBDC-453496E46AE0Q28386160-B85C60D8-5B90-40C2-A9D1-D5B81726DCADQ33847509-315F6112-B67B-4D9F-BD0A-02864DEA41E0Q33935368-3ADBDB46-454C-4E53-B75C-DC7EB7959484Q34074975-E634F897-5886-4954-92DF-1BE3925F825DQ34268695-CEC94EF8-6D75-414E-829F-0D14802B525DQ34457540-D7A87830-BC02-4652-AAD0-74B1E434D4F4Q34558661-2158748F-B3FE-4097-926D-FE7114B6EFB3Q34652418-54B15E86-E4BB-4EE0-9AD5-0A4A3883F519Q34795807-049A8273-4C91-4DA3-ABDA-41C010899128Q35702259-CFCADE87-47E0-47F4-9BF3-08EE694FCA54Q35925366-2C89DD3F-15F3-4838-A804-6B42CB41A518Q36095874-6B24E06C-BE69-4702-86BF-E67D5499A0A9Q36268383-20ABFC34-7B86-43AE-A198-0DF75CDB86E5Q36422966-20794B87-BDA2-49EA-B81C-E4753A32356AQ36787187-6B069E90-9265-484B-B2EC-27E17C217887Q36788370-2DF9DE73-A667-4585-9169-26212951BFE9Q36870716-6612F33F-B52E-4BBF-A242-E91A8BBB88FEQ37013020-0CFFF80D-4E61-4D73-8F35-AAED87B2DA44Q37029217-D523B1C0-6DDC-4D39-92DC-5D1249557009Q37123788-1895BC2E-1918-4CC9-9390-FD23190F86B1Q37181232-71B7301E-7D9D-43DD-A2ED-7CD31087C4B2Q37215935-3B6655B0-4647-4A5E-A12B-4727075953CFQ37418760-D96D3241-2A8C-4869-B5B7-B075E8AA63ADQ37583907-0ECD50F5-5EBA-46BE-BEA4-D0D26A7EBC53Q37910022-BC71A8ED-CD0A-4E3C-B804-03E3869ADD33Q37915360-A3D67B09-6573-4777-9911-9FB35B7D89F4Q37949636-51ED4A50-BD54-4A41-922A-FD0FC8455BACQ38058355-A6947F60-2F23-4123-8BF9-423447FDAA84Q38394222-864FF297-5DF6-458B-B0A3-4A9438B977FDQ38414785-4B7183BC-955D-409F-B1EF-A3D43FAA2E3EQ39894808-CF9C56FB-ED8C-4E2A-991D-08245A415A02Q41873181-3C73320C-044E-4AA1-A84C-22CF81F57B1AQ42546631-33C0990D-32A8-4986-B249-733EC036AFE6Q46408439-CC854460-0403-41B6-8444-5098F57D838F
P2860
Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Treatment of nosocomial pneumo ...... osa with aerosolized colistin.
@en
Treatment of nosocomial pneumo ...... osa with aerosolized colistin.
@nl
type
label
Treatment of nosocomial pneumo ...... osa with aerosolized colistin.
@en
Treatment of nosocomial pneumo ...... osa with aerosolized colistin.
@nl
prefLabel
Treatment of nosocomial pneumo ...... osa with aerosolized colistin.
@en
Treatment of nosocomial pneumo ...... osa with aerosolized colistin.
@nl
P2860
P921
P1476
Treatment of nosocomial pneumo ...... osa with aerosolized colistin.
@en
P2860
P304
P356
10.1164/AJRCCM.162.1.9910071
P407
P577
2000-07-01T00:00:00Z